A randomized, controlled phase 3 study, Liberty Asthma Quest, evaluating the efficacy and safety of dupilumab in uncontrolled moderate-to-severe asthma
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Conference item |
Published: |
American Thoracic Society
2018
|